Keeps Biopharma Inc. Logo

Keeps Biopharma Inc.

Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.

256940 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 화성시 동탄면 동탄산단10길 52, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Keeps Biopharma Inc. is a company with diversified operations in biopharmaceuticals and industrial manufacturing. The biopharmaceutical division focuses on the research and development of biomarker-driven targeted therapies for women's cancers, including ovarian, endometrial, and triple-negative breast cancer. The company is also advancing an oral obesity drug, which is reportedly undergoing primate trials. Operating under its former name, KPS Corp, the company's industrial segment manufactures and sells mechanical equipment for the flat panel display industry and produces cleanroom consumables such as wipers and adhesive rolls.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 00:00
M&A Activity
주요사항보고서(유형자산양수결정)
Korean 15.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-07-23 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.1 KB
2025-07-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 89.0 KB
2025-06-17 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 97.4 KB
2025-06-17 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.2 KB
2025-06-16 00:00
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
Korean 91.6 KB
2025-05-30 00:00
Share Issue/Capital Change
전환청구권행사
Korean 14.1 KB
2025-05-15 00:00
Annual Report
분기보고서 (2025.03)
Korean 1.7 MB
2025-04-10 00:00
M&A Activity
합병등종료보고서(합병)
Korean 16.9 KB
2025-04-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB
2025-04-09 00:00
M&A Activity
주요사항보고서(타법인주식및출자증권양도결정)
Korean 21.7 KB
2025-03-31 00:00
Capital/Financing Update
기타경영사항(자율공시) (제5회차 무기명식 무보증 사모 전환사채 재매각의 건)
Korean 12.2 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 26.3 KB
2025-03-28 00:00
Post-Annual General Meeting Information
상호변경안내
Korean 5.6 KB

Automate Your Workflow. Get a real-time feed of all Keeps Biopharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Keeps Biopharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.